The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis - in vivo study by high-resolution magnetic resonance imaging

Author： Corti R.   Osende J.I.   Fallon J.T.   Fuster V.   Mizsei G.   Jneid H.   Wright S.D.   Chaplin W.F.   Badimon J.J.  

Publisher： Elsevier

ISSN： 0735-1097

Source： Journal of the American College of Cardiology, Vol.43, Iss.3, 2004-02, pp. : 464-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S.   Cowan D.   Kaski J.-C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1757-1763

Elsevier

Access to resources Recommend Favorite

Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor α/γ agonist on glucose uptake

By Hu X.   Feng Y.   Liu X.   Zhao X.-F.   Yu J.-H.   Yang Y.-S.   Sydow-Bäckman M.   Hörling J.   Zierath J.   Leng Y.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1048-1057

Springer Publishing Company

Access to resources Recommend Favorite

Partial Peroxisome Proliferator-Activated Receptor Agonist Angiotensin Receptor Blockers

By  

Cerebrovascular Diseases, Vol. 26, Iss. 2, 2008-06 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation

By Yoshida T.   Yamagishi S.   Nakamura K.   Matsui T.   Imaizumi T.   Takeuchi M.   Koga H.   Ueno T.   Sata M.  

Diabetologia, Vol. 49, Iss. 12, 2006-12 ,pp. : 3094-3099

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Peroxisome Proliferator-Activated Receptor Gamma for Generation of Antidiabetic Drug

By  

Current Diabetes Reviews, Vol. 9, Iss. 4, 2013-07 ,pp. : 275-285

Bentham Science Publishers

Access to resources Recommend Favorite